Clinical trial NCT06693700: A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
Official title: Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Smoking
Smoking Cessation
Smoking Reduction
Smoking Habit
Smoking Behaviors
Smoking, Tobacco
Smoking, Cigarette
Smoking (Tobacco) Addiction
Tobacco Use
Tobacco Smoking
Keywords: smoking
smoking cessation
smoking reduction
smoking habit
smoking behaviors
smoking, tobacco
smoking, cigarette
smoking (tobacco) addiction
tobacco use
tobacco smoking
air quality
indoor air quality monitoring devices
24-260
Memorial Sloan Kettering Cancer Center
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
First posted: 2024-11-18
Enrollment: 10
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: PREVENTION

Brief summary: The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.


Eligibility criteria: Inclusion Criteria:

* Adult (aged \>18 years) MSK patients as per the EHR
* Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database
* Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form
* Must be English-speaking in the EHR
* Must be reachable by phone as per self-report
* Must have Wi-Fi available at home as per self-report

Exclusion Criteria:

* Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

Primary outcomes:
measure: Percentage of participants using the air quality monitoring device for 14 consecutive days
timeFrame: up to 8 weeks
measure: Percentage of participants who attend the study-specific smoke-free workshop sessions
timeFrame: Up to 8 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Basking Ridge
country: United States
facility: Memorial Sloan Kettering Basking Ridge (Consent only)
state: New Jersey
city: Middletown
country: United States
facility: Memorial Sloan Kettering Monmouth (Consent only)
state: New Jersey
city: Montvale
country: United States
facility: Memorial Sloan Kettering Bergen (Consent only)
state: New Jersey
city: Commack
country: United States
facility: Memorial Sloan Kettering Suffolk-Commack (Consent only)
state: New York
city: Harrison
country: United States
facility: Memorial Sloan Kettering Westchester (Consent only)
state: New York
city: New York
country: United States
facility: City College of New York (Data Collection AND Data Analysis)
state: New York
city: New York
country: United States
facility: Memorial Sloan Kettering Cancer Center (All Protocol Activities)
state: New York
city: Uniondale
country: United States
facility: Memorial Sloan Kettering Nassau (Consent only)
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: Jamie Ostroff, PhD
role: PRINCIPAL_INVESTIGATOR
References: